Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
NCT ID:
NCT06692712
Brief Title:
Phase 3, Open-label Study to Assess the Efficacy and Safety of a Single Lumbar Intrathecal Administration of MELPIDA in Individuals with Hereditary Spastic Paraplegia Type 50 (SPG50) Versus Matched Prospective Concurrent Controls.
Official Title:
Intrathecal Administration of MELPIDA (AAV9/AP4M1) for Hereditary Spastic Paraplegia Type 50 (SPG50): a Phase 3, Open-Label Trial with Matched Prospective Concurrent Control Arm
Acronym:
SPG50
Study:
NCT06692712
Protocol Section:
NCT06692712